Cachexia and sarcopenia: mechanisms and potential targets for intervention.

Abstract:

:Cachexia is a multi-organ syndrome associated with cancer and other chronic diseases, characterized by body weight loss, muscle and adipose tissue wasting and inflammation, being often associated with anorexia. Skeletal muscle tissue represents more than 40% of body weight and seems to be one of the main tissues involved in the wasting that occurs during cachexia. Sarcopenia is a degenerative loss of skeletal muscle mass, quality, and strength associated with healthy ageing. The molecular mechanisms behind cachexia and sarcopenia share some common trends. Muscle wasting is the result of a combination of an imbalance between synthetic and degradative protein pathways together with increased myocyte apoptosis and decreased regenerative capacity. Oxidative pathways are also altered in skeletal muscle during muscle wasting and this seems to be a consequence of mitochondrial abnormalities that include altered morphology and function, decreased ATP synthesis and uncoupling. The aim of the present review is to analyse common molecular pathways between cachexia and sarcopenia in order to put forward potential targets for intervention.

journal_name

Curr Opin Pharmacol

authors

Argilés JM,Busquets S,Stemmler B,López-Soriano FJ

doi

10.1016/j.coph.2015.04.003

subject

Has Abstract

pub_date

2015-06-01 00:00:00

pages

100-6

eissn

1471-4892

issn

1471-4973

pii

S1471-4892(15)00040-5

journal_volume

22

pub_type

杂志文章,评审
  • Drugs targeting functional bowel disorders: insights from animal studies.

    abstract::Increased understanding of gastrointestinal pathophysiology in functional bowel disorders is leading to improved focus on relevant enteric, vagal and spinal afferent nervous systems, and targets operating on these systems. These targets include receptors for tachykinins, motilin, ghrelin, corticotropin-releasing facto...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00228-x

    authors: Sanger GJ,Hicks GA

    更新日期:2002-12-01 00:00:00

  • Small molecule drugs - optimizing DNA damaging agent-based therapeutics.

    abstract::DNA-targeted chemotherapies remain fundamental in clinical management of both common solid tumours and hematologic malignancies. Recent studies indicate that novel combinations of cytotoxic chemotherapy may have significant activity even in tumours regarded as being resistant to conventional chemotherapy. In addition,...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.03.008

    authors: Hartley JA,Hochhauser D

    更新日期:2012-08-01 00:00:00

  • The case for a role for adenosine in asthma: almost convincing?

    abstract::Mice rendered adenosine deaminase-deficient manifest an 'asthma' phenotype in the lungs that includes mast cell degranulation, eosinophilia, mucus hypersecretion and bronchial hyperresponsiveness. These changes can be reversed by enzyme therapy with adenosine deaminase, and attenuated by theophylline. Theophylline als...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(03)00039-0

    authors: Fozard JR

    更新日期:2003-06-01 00:00:00

  • Role of HMGB1 in cardiovascular diseases.

    abstract::A nuclear protein, high mobility group box 1 (HMGB1), is released passively by necrotic cells, and actively by macrophages/monocytes in response to exogenous and endogenous inflammatory stimuli. After binding to the receptor for advanced glycation end products (RAGE) or toll-like receptor 4 (TLR4), HMGB1 activates vas...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.10.010

    authors: Li W,Sama AE,Wang H

    更新日期:2006-04-01 00:00:00

  • Extracellular matrix molecules: endogenous danger signals as new drug targets in kidney diseases.

    abstract::Extracellular matrix (ECM) components, commonly thought to function purely as structural elements are now demonstrated to act as signaling molecules. With the identification of matrix-derived endogenous ligands of Toll-like and NOD-like receptors of innate immunity, a general question about the mechanisms of soluble E...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2009.11.007

    authors: Schaefer L

    更新日期:2010-04-01 00:00:00

  • Neurotrophic effects of antidepressant drugs.

    abstract::The past decade has witnessed a growing interest in the trophic effects of antidepressant drugs. Antidepressants stimulate the production and signaling of plasticity-related proteins such as neurotrophins and cAMP response element binding protein, and neurotrophin signaling appears to be both sufficient and necessary ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2003.10.004

    authors: Castrén E

    更新日期:2004-02-01 00:00:00

  • The brain hypocretins and their receptors: mediators of allostatic arousal.

    abstract::The hypocretins (abbreviated 'Hcrts' - also called 'orexins') are two neuropeptides secreted exclusively by a small population of neurons in the lateral hypothalamus. These peptides bind to two receptors located throughout the brain in nuclei associated with diverse cognitive and physiological functions. Initially, th...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2008.12.018

    authors: Carter ME,Schaich Borg J,de Lecea L

    更新日期:2009-02-01 00:00:00

  • Non-neuronal cholinergic airway epithelium biology.

    abstract::Acetylcholine, a major regulator of airway function, is not solely produced by neurons but also by a variety of non-neurons cells including various airway epithelial cells utilizing a molecular machinery of acetylcholine synthesis and release that differs from that of neurons. While canonical neuronal cholinergic sign...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.03.001

    authors: Kummer W,Krasteva-Christ G

    更新日期:2014-06-01 00:00:00

  • VEGF as a potential target for therapeutic intervention in depression.

    abstract::Antidepressants are among the most widely prescribed drugs, however the mechanism underlying their therapeutic efficacy is not known. Neurotrophic factors represent a promising class of targets for antidepressant treatments. We recently characterized a role for vascular endothelial growth factor (VEGF) in cellular and...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2007.10.013

    authors: Warner-Schmidt JL,Duman RS

    更新日期:2008-02-01 00:00:00

  • The role of the adipocyte hormone adiponectin in cardiovascular disease.

    abstract::Adiponectin, a novel hormone made by fat tissue, regulates energy metabolism and endothelial activation. Serum levels of adiponectin are reduced in conditions that are associated with an increased risk of cardiovascular disease, such as diabetes and the metabolic syndrome. Adiponectin trimers assemble into higher-orde...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.01.001

    authors: Hug C,Lodish HF

    更新日期:2005-04-01 00:00:00

  • Targeting the 5-HT(3) receptor in the treatment of irritable bowel syndrome.

    abstract::Irritable bowel syndrome, which affects 5-10% of the population includes around 25% with predominantly diarrhoea (IBS-D). Several lines of evidence suggest an increase in mucosal 5-HT availability in IBS-D including a decrease in the serotonin transporter (SERT) which is also seen following acute diverticulitis. 5-HT(...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.02.005

    authors: Spiller RC

    更新日期:2011-02-01 00:00:00

  • Two way communication between neutrophils and dendritic cells.

    abstract::Neutrophils are instrumental in innate immunity by mediating immediate removal of pathogens. Recent findings demonstrate that they are able to communicate with dendritic cells, which form a link between innate and adaptive immunity by stimulating long-term memory T cell responses. This communication occurs through the...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.03.009

    authors: Ludwig IS,Geijtenbeek TB,van Kooyk Y

    更新日期:2006-08-01 00:00:00

  • Host immune modulation by antimicrobial drugs: current knowledge and implications for antimicrobial chemotherapy.

    abstract::It is known that antimicrobial agents possess several, beneficial, secondary properties which complement their primary antimicrobial activity like the immunomodulatory capacity that enforces host defense mechanisms or reduces host inflammatory response. In this review the current state of our recent research about the...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.07.011

    authors: Banche G,Allizond V,Mandras N,Tullio V,Cuffini AM

    更新日期:2014-10-01 00:00:00

  • Gasotransmitters in health and disease: a mitochondria-centered view.

    abstract::Gasotransmitters fulfill important roles in cellular homeostasis having been linked to various pathologies, including inflammation and cardiovascular diseases. In addition to the known pathways mediating the actions of gasotransmitters, their effects in regulating mitochondrial function are emerging. Given that mitoch...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.07.001

    authors: Hendriks KD,Maassen H,van Dijk PR,Henning RH,van Goor H,Hillebrands JL

    更新日期:2019-04-01 00:00:00

  • A role for the gut-to-brain GLP-1-dependent axis in the control of metabolism.

    abstract::Over the past years tremendous amounts of clinical and fundamental data have been generated about GLP-1 and related therapeutic strategies for the treatment of type 2 diabetes. However, the cellular and physiological mechanisms through which GLP-1 is secreted, controls glycemia, and behaves as a therapeutic agent are ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2009.09.003

    authors: Burcelin R,Serino M,Cabou C

    更新日期:2009-12-01 00:00:00

  • New approaches to targeting the bone marrow microenvironment in multiple myeloma.

    abstract::Multiple myeloma is a tumour with a remarkably destructive effect on its host organ, the bone marrow. Through expression or secretion of adhesion molecules, growth factors, exosomes, miRNAs, chemokines and inhibitors, the tumour substantially alters its microenvironment, promoting both tumour survival and osteolytic b...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2016.02.013

    authors: Gooding S,Edwards CM

    更新日期:2016-06-01 00:00:00

  • The role of chemokines in intestinal inflammation and cancer.

    abstract::Chronic inflammation is a risk factor for several gastrointestinal malignancies, including colorectal cancer. Recent epidemiological studies and clinical trials demonstrate that long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) markedly reduced the relative risk of colorectal cancer. Chronic inflammation...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2009.08.003

    authors: Wang D,Dubois RN,Richmond A

    更新日期:2009-12-01 00:00:00

  • The present state of the tuberculosis drug development pipeline.

    abstract::Tuberculosis now ranks as the leading cause of death in the world due to a single infectious agent. Current standard of care treatment can achieve very high cure rates for drug-sensitive disease but requires a 6-month duration of chemotherapy. Drug-resistant disease requires significantly longer treatment durations wi...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.08.001

    authors: J Libardo MD,Boshoff HI,Barry CE 3rd

    更新日期:2018-10-01 00:00:00

  • Immunomodulation in stem-cell transplantation.

    abstract::Acute graft-versus-host disease is a complication that affects 30-60% of patients undergoing allogeneic stem-cell transplantation. The standard for prophylaxis for graft-versus-host disease has historically been the combination of cyclosporine and methotrexate. Recently, tacrolimus has been used more frequently and cu...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00174-1

    authors: Abo-Zena RA,Horwitz ME

    更新日期:2002-08-01 00:00:00

  • 2-5A antisense treatment of respiratory syncytial virus.

    abstract::Although a prominent cause of upper and lower respiratory tract disease in infants and the elderly, clinical options for treatment of respiratory syncytial virus (RSV) infections remain limited. Historically, attempts to develop vaccines have been unsuccessful, and rapid viral mutation rates have stifled development o...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.05.003

    authors: Leaman DW

    更新日期:2005-10-01 00:00:00

  • GABAB receptor modulation-to B or not to be B a pro-cognitive medicine?

    abstract::Metabotropic GABAB receptors clearly modify cognitive performance in preclinical animal models, yet translation to treating human disease has been elusive. Compared to their ionotropic GABAA receptor counterpart GABAB receptors not only regulate postsynaptic excitability but also regulate diverse synaptic inputs by pr...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2017.09.012

    authors: Serrats J,Cunningham MO,Davies CH

    更新日期:2017-08-01 00:00:00

  • Promoting apoptosis in disease management: a panacea or Trojan horse?

    abstract::In our enthusiasm to advocate apoptosis as a therapeutic strategy for the management of disease we need to be mindful that the clearance of apoptotic cells is itself immunomodulatory and that it may not always be as benign or beneficial as we think. Indeed, the existence of free apoptotic cells in situ may potentially...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.02.005

    authors: Brown SB,Vernon-Wilson EF

    更新日期:2005-08-01 00:00:00

  • Angiotensin type 2 receptors: blood pressure regulation and end organ damage.

    abstract::In most situations, the angiotensin AT2-receptor (AT2R) mediates physiological actions opposing those mediated by the AT1-receptor (AT1R), including a vasorelaxant effect. Nevertheless, experimental evidence vastly supports that systemic application of AT2R-agonists is blood pressure neutral. However, stimulation of A...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2015.01.004

    authors: Sumners C,de Kloet AD,Krause EG,Unger T,Steckelings UM

    更新日期:2015-04-01 00:00:00

  • GABA(A)-receptor subtypes: a new pharmacology.

    abstract::The GABA(A) receptor is a pluripotent drug target mediating anxiolytic, sedative, anticonvulsant, muscle relaxant and amnesic activity. These drug actions have now been attributed to defined receptor subtypes. Thus, precise guidelines are available for the development of novel drugs with more selective action and less...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(01)00008-x

    authors: Möhler H,Crestani F,Rudolph U

    更新日期:2001-02-01 00:00:00

  • New and emerging anti-fibrotic therapeutics entering or already in clinical trials in chronic liver diseases.

    abstract::Chronic liver diseases with different etiologies represent a major public health issue worldwide. Liver fibrosis is the common feature of almost all chronic liver diseases and remains a key determinant of clinical prognosis. Over the last two decades, basic science studies have uncovered molecular mechanisms underlyin...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.09.006

    authors: Lemoinne S,Friedman SL

    更新日期:2019-12-01 00:00:00

  • Treatment of orthostatic hypotension.

    abstract::Orthostatic hypotension (OH) is a fall in blood pressure after assuming an upright position. Whereas asymptomatic patients usually need no treatment, the majority of symptomatic patients can be cured by avoidance of trigger mechanisms and the use of physical countermaneuvers and non-pharmacological interventions. Seve...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00213-8

    authors: Oldenburg O,Kribben A,Baumgart D,Philipp T,Erbel R,Cohen MV

    更新日期:2002-12-01 00:00:00

  • Controlling ionotropic and metabotropic glutamate receptors with light: principles and potential.

    abstract::Light offers unique advantages for studying and manipulating biomolecules and the cellular processes that they control. Optical control of ionotropic and metabotropic glutamate receptors has garnered significant interest, since these receptors are central to signaling at neuronal synapses and only optical approaches p...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.12.008

    authors: Reiner A,Levitz J,Isacoff EY

    更新日期:2015-02-01 00:00:00

  • Developments in parathyroid hormone and related peptides as bone-formation agents.

    abstract::Osteoporosis is a major and growing healthcare concern. When administered by daily injection, parathyroid hormone (PTH) and its N-terminal fragments and analogs are potent bone-formation agents. Teriparatide, recombinant human PTH(1-34), is likely to be the first anabolic agent approved for treating osteoporosis, desp...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00154-6

    authors: Fox J

    更新日期:2002-06-01 00:00:00

  • The role of TLRs in neutrophil activation.

    abstract::Neutrophils are key innate immune effector cells that are rapidly recruited to sites of infection and inflammation to provide early defence against invading microorganisms. This function is facilitated by the expression of Toll-like receptor (TLR) family members by neutrophils, allowing the recognition of an extensive...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.06.007

    authors: Prince LR,Whyte MK,Sabroe I,Parker LC

    更新日期:2011-08-01 00:00:00

  • Current drug development portfolio for antimalarial therapies.

    abstract::In response to the emergence of parasite drug resistance to currently deployed antimalarials, the scientific community, in partnership with the pharmaceutical industry and public organizations, has fashioned an antimalarial drug development portfolio for the sustained development and registration of safe, effective an...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.05.004

    authors: Biagini GA,O'Neill PM,Bray PG,Ward SA

    更新日期:2005-10-01 00:00:00